申请人:Moore, II Bob M.
                            
                            
                                公开号:US20110046163A1
                            
                            
                                公开(公告)日:2011-02-24
                            
                            Furanopyrimidine cannabinoid analog compounds of the formula I are disclosed.
The compounds are useful to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.